Sakar Healthcare Limited has informed the Exchange regarding Appointment of Mr Nimesh Suthar as Senior Vice President (International Business) of the company w.e.f. July 25, 2025.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sakar Healthcare's Board, at its meeting on July 25, 2025, approved the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025) and fixed September 23, 2025 as the date for the 21st AGM via video conferencing. Three new Independent Directors — Ms. Megha Samdani, Ms. Reeya Kothari, and Ms. Hiral Patel — were appointed for five-year terms, subject to shareholder approval. The Board also appointed M/s. Nishant Pandya & Associates as Secretarial Auditor (5-year term, FY 2025-26 to FY 2029-30) and M/s. Dalwadi & Associates as Cost Auditor for FY 2025-26. Additionally, three senior management personnel were appointed: Mr. Sudhir Ghule as COO, Mr. Raviraj Karia as SVP (Finance & Accounts), and Mr. Nimesh Suthar as SVP (International Business), all effective July 25, 2025.
This is a routine governance update with multiple board and senior management strengthening moves. The new appointees bring deep pharma industry experience (from companies like Dr. Reddy's, Sun Pharma, Cipla, Zydus, Baxter, and Intas), which could support the company's domestic and international business expansion.